These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36567122)

  • 21. Effective Vaccination and Education Strategies for Emerging Infectious Diseases Such as COVID-19.
    Wie SH; Jung J; Kim WJ
    J Korean Med Sci; 2023 Nov; 38(44):e371. PubMed ID: 37967881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Vaccination and Control Measures on the Fatality of COVID-19: An Ecological Study.
    Tan J; Wu Z; Gan L; Zhong Q; Zhu Y; Li Y; Zhang D
    J Epidemiol Glob Health; 2022 Dec; 12(4):456-471. PubMed ID: 36161649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Descriptive analysis to assess seasonal patterns of COVID-19 and influenza in low-income and middle-income countries in Asia, the Middle East and Latin America.
    Kyaw MH; Spinardi JR; Jagun O; Franco Villalobos C; Kapetanakis V; Sharf-Williams R; Yarnoff B
    BMJ Open; 2024 Jan; 14(1):e081019. PubMed ID: 38296298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beyond Influenza Vaccination: Expanding Infrastructure for Hospital-based Pediatric COVID-19 Vaccine Delivery.
    Hofstetter AM; Rao S; Jhaveri R
    Clin Ther; 2022 Mar; 44(3):450-455. PubMed ID: 35172946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Consideration on implementation of co-administration of Seasonal Influenza and COVID-19 vaccines during pandemic in China].
    Zhang T; Bai XF; Wang W; Liu XX; Zhang XX; Wang DY; Zhang SB; Chen ZP; He HQ; Huang ZY; Xu AQ; Peng ZB; Feng LZ; Yu WZ; Feng Z
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Feb; 56(2):103-107. PubMed ID: 34954956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased Case Fatality Rate of COVID-19 in the Second Wave: A study in 53 countries or regions.
    Fan G; Yang Z; Lin Q; Zhao S; Yang L; He D
    Transbound Emerg Dis; 2021 Mar; 68(2):213-215. PubMed ID: 32892500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seesaw Effect Between COVID-19 and Influenza From 2020 to 2023 in World Health Organization Regions: Correlation Analysis.
    Wang Q; Jia M; Jiang M; Liu W; Yang J; Dai P; Sun Y; Qian J; Yang W; Feng L
    JMIR Public Health Surveill; 2023 Jun; 9():e44970. PubMed ID: 37191650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis.
    COVID-19 Forecasting Team
    Lancet; 2022 Apr; 399(10334):1469-1488. PubMed ID: 35219376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acceptance of seasonal influenza vaccination and associated factors among pregnant women in the context of COVID-19 pandemic in China: a multi-center cross-sectional study based on health belief model.
    Wang R; Tao L; Han N; Liu J; Yuan C; Deng L; Han C; Sun F; Chi L; Liu M; Liu J
    BMC Pregnancy Childbirth; 2021 Nov; 21(1):745. PubMed ID: 34732157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022.
    Link-Gelles R; Levy ME; Gaglani M; Irving SA; Stockwell M; Dascomb K; DeSilva MB; Reese SE; Liao IC; Ong TC; Grannis SJ; McEvoy C; Patel P; Klein NP; Hartmann E; Stenehjem E; Natarajan K; Naleway AL; Murthy K; Rao S; Dixon BE; Kharbanda AB; Akinseye A; Dickerson M; Lewis N; Grisel N; Han J; Barron MA; Fadel WF; Dunne MM; Goddard K; Arndorfer J; Konatham D; Valvi NR; Currey JC; Fireman B; Raiyani C; Zerbo O; Sloan-Aagard C; Ball SW; Thompson MG; Tenforde MW
    MMWR Morb Mortal Wkly Rep; 2022 Jul; 71(29):931-939. PubMed ID: 35862287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant?
    Duong BV; Larpruenrudee P; Fang T; Hossain SI; Saha SC; Gu Y; Islam MS
    Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between seasonal flu vaccination and COVID-19 among healthcare workers.
    Belingheri M; Paladino ME; Latocca R; De Vito G; Riva MA
    Occup Med (Lond); 2020 Dec; 70(9):665-671. PubMed ID: 33300998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring trends and differences in COVID-19 case-fatality rates using decomposition methods: Contributions of age structure and age-specific fatality.
    Dudel C; Riffe T; Acosta E; van Raalte A; Strozza C; Myrskylä M
    PLoS One; 2020; 15(9):e0238904. PubMed ID: 32913365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of healthcare-associated SARS-CoV-2 outbreaks in Germany between March 2020 and May 2022.
    Suwono B; Brandl M; Hecht J; Eckmanns T; Haller S
    J Hosp Infect; 2023 Apr; 134():108-120. PubMed ID: 36738991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Online Search Trends With Vaccination in the United States: June 2020 Through May 2021.
    Berning P; Huang L; Razavi AC; Boakye E; Osuji N; Stokes AC; Martin SS; Ayers JW; Blaha MJ; Dzaye O
    Front Immunol; 2022; 13():884211. PubMed ID: 35514956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different clinical guidelines, common goal: To reduce COVID-19 mortality.
    Sun L; Liu J; Zhao F; Chen J; Lu H
    Biosci Trends; 2023 Mar; 17(1):78-80. PubMed ID: 36682801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temporal changes to adult case fatality risk of COVID-19 after vaccination in England between May 2020 and February 2022: a national surveillance study.
    Halford F; Yates K; Clare T; Lopez-Bernal J; Kall M; Allen H
    J R Soc Med; 2023 Dec; ():1410768231216332. PubMed ID: 38096898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany.
    Molnar D; Anastassopoulou A; Poulsen Nautrup B; Schmidt-Ott R; Eichner M; Schwehm M; Dos Santos G; Ultsch B; Bekkat-Berkani R; von Krempelhuber A; Van Vlaenderen I; Van Bellinghen LA
    Hum Vaccin Immunother; 2022 Nov; 18(5):2058304. PubMed ID: 35486410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The COVID-19 and Influenza "Twindemic": Barriers to Influenza Vaccination and Potential Acceptance of SARS-CoV2 Vaccination in African Americans.
    Ferdinand KC; Nedunchezhian S; Reddy TK
    J Natl Med Assoc; 2020 Dec; 112(6):681-687. PubMed ID: 33276969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.